Financials
- Market Capitalization 62.45 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.59
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4157 | SER Serina Therapeutics, Inc. Common Stock | 2.52 USD | +2.44% | -4.55% | +25.37% | +51.35% | 64.01 M USD | ||
| 4161 | ELOX Eloxx Pharmaceuticals, Inc. | 15.01 USD | -10.49% | -21.45% | -17.71% | +50.10% | 60.59 M USD | ||
| 4174 | HYFT MindWalk Holdings Corp. - Common Stock | 1.30 USD | -2.99% | -8.45% | +0.78% | -35.64% | 60.73 M USD | ||
| 4183 | APLM Apollomics Inc. - Class A Ordinary Shares | 26.94 USD | -0.55% | +8.19% | +53.24% | +583.76% | 59.16 M USD |